Empresa
Sobre Nosotros
Nuestro Equipo
Descubrimientos
Programas
Publicaciones
Seleccionadas
Todas
EN
Contacto
Galectin-1 as a potential cancer target
Galectin-1 as a potential cancer target
Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease
Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis
The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders
Overexpression of inducible nitric oxide synthase and cyclooxygenase-2 in rat zinc-deficient lung: Involvement of a NF-kappaB dependent pathway
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis
Regulated expression of galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis
Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis
Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model
